Cwm LLC Boosts Stock Position in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Cwm LLC lifted its position in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report) by 1,212,300.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,124 shares of the company’s stock after buying an additional 12,123 shares during the period. Cwm LLC’s holdings in BlackRock Health Sciences Term Trust were worth $178,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Carmel Capital Partners LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the 3rd quarter worth approximately $92,000. Stratos Wealth Advisors LLC bought a new stake in BlackRock Health Sciences Term Trust in the fourth quarter worth $170,000. Blue Bell Private Wealth Management LLC boosted its position in BlackRock Health Sciences Term Trust by 229.3% during the third quarter. Blue Bell Private Wealth Management LLC now owns 14,792 shares of the company’s stock valued at $213,000 after buying an additional 10,300 shares during the period. Ieq Capital LLC bought a new position in shares of BlackRock Health Sciences Term Trust during the third quarter valued at about $223,000. Finally, B. Riley Wealth Advisors Inc. increased its holdings in shares of BlackRock Health Sciences Term Trust by 4.8% in the third quarter. B. Riley Wealth Advisors Inc. now owns 17,363 shares of the company’s stock worth $250,000 after buying an additional 796 shares during the period.

Insider Transactions at BlackRock Health Sciences Term Trust

In other news, major shareholder Saba Capital Management, L.P. purchased 93,967 shares of the stock in a transaction that occurred on Monday, February 5th. The stock was bought at an average cost of 15.56 per share, for a total transaction of 1,462,126.52. Following the acquisition, the insider now directly owns 18,690,059 shares of the company’s stock, valued at approximately 290,817,318.04. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Over the last 90 days, insiders have bought 1,142,444 shares of company stock worth $18,333,831.

BlackRock Health Sciences Term Trust Price Performance

NYSE BMEZ opened at 15.10 on Friday. The stock has a 50-day moving average of 15.71 and a 200-day moving average of 14.96. BlackRock Health Sciences Term Trust has a 1-year low of 12.93 and a 1-year high of 16.59.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be paid a dividend of $0.09 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 7.15%. The ex-dividend date is Tuesday, May 14th.

About BlackRock Health Sciences Term Trust

(Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

Featured Stories

Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report).

Institutional Ownership by Quarter for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.